Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Systemic Lupus Erythematosus
100%
Anxiety Symptoms
83%
Depressive Symptoms
66%
Anxiety Scale
66%
Hospital Anxiety
66%
Depression Scale
66%
Disease Activity
50%
National Hospital
33%
Systemic Disease
33%
Systemic Lupus Erythematosus Patient
33%
SLE Disease Activity Index (SLEDAI)
33%
Mexican
33%
Lupus Erythematosus Systemic
33%
Symptom-based Approach
33%
Serum Levels
16%
HPA Axis
16%
Chronic Disease
16%
Quality of Life
16%
Depressed Patients
16%
Disability
16%
Spearman Correlation Test
16%
Blood Samples
16%
Statistical Significance
16%
Inflammatory Cytokines
16%
Weak Correlation
16%
Inflammatory Process
16%
Drug Adverse Effects
16%
Neuropsychiatric Involvement
16%
Complement C3
16%
Complement C4
16%
Neurotransmitter Disorders
16%
Immunological Dysregulation
16%
Anxious Symptoms
16%
Scale Questionnaire
16%
Poor Connection
16%
Nursing and Health Professions
Systemic Lupus Erythematosus
100%
Disease Activity
50%
Hospital Anxiety and Depression Scale
40%
Systemic Disease
20%
Blood Level
10%
Adverse Drug Reaction
10%
Psychosomatic Disorder
10%
Complement Component C3
10%
Symptomatology
10%
Polyvinylpyridine 1 Oxide
10%
Complement Component C4
10%
Neurotransmitter
10%
Cross-Sectional Study
10%
Quality of Life
10%
Chronic Condition
10%
Cytokine
10%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Disease Activity
50%
Hospital Anxiety and Depression Scale
40%
Systemic Disease
20%
Quality of Life
10%
Cytokine
10%
Adverse Drug Reaction
10%
Symptomatology
10%
Polyvinylpyridine 1 Oxide
10%
Psychosomatic Disorder
10%
Complement Component C3
10%
Neurotransmitter
10%
Complement Component C4
10%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
100%
Disease Activity
50%
Systemic Disease
20%
Adverse Drug Reaction
10%
Cytokine
10%
Neurotransmitter
10%
Polyvinylpyridine 1 Oxide
10%
Psychosomatic Disorder
10%
Symptomatology
10%
Complement Component C4
10%
Complement Component C3
10%
Cross-Sectional Study
10%